Evidence map›Paper›PMID 38736483›Full record

ArticleFrontiers in molecular neuroscience2024

Slitrk4 is required for the development of inhibitory neurons in the fear memory circuit of the lateral amygdala.

Yoshifumi Matsumoto, Hideki Miwa, Kei-Ichi Katayama, Arata Watanabe, Kazuyuki Yamada, Takashi Ito, Shinsuke Nakagawa, Jun Aruga

Abstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yoshifumi MatsumotoLaboratory for Behavioral and Developmental Disorders, RIKEN Brain Science Institute, Wako-shi, Japan.
Hideki MiwaDepartment of Genetic and Behavioral Neuroscience, Gunma University Graduate School of Medicine, Maebashi, Japan.
Kei-Ichi KatayamaLaboratory for Behavioral and Developmental Disorders, RIKEN Brain Science Institute, Wako-shi, Japan.
Arata WatanabeDepartment of Medical Pharmacology, Nagasaki University Institute of Biomedical Sciences, Nagasaki, Japan.
Kazuyuki YamadaSupport Unit for Animal Experiments, RIKEN Brain Science Institute, Wako-shi, Japan.
Takashi ItoDepartment of Biochemistry, Nagasaki University Institute of Biomedical Sciences, Nagasaki, Japan.
Shinsuke NakagawaDepartment of Medical Pharmacology, Nagasaki University Institute of Biomedical Sciences, Nagasaki, Japan.
Jun ArugaLaboratory for Behavioral and Developmental Disorders, RIKEN Brain Science Institute, Wako-shi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Slitrk family consists of six synaptic adhesion molecules, some of which are associated with neuropsychiatric disorders. In this study, we aimed to investigate the physiological role of Slitrk4 by analyzing Slitrk4 knockout (KO) mice. The Slitrk4 protein was widely detected in the brain and was abundant in the olfactory bulb and amygdala. In a systematic behavioral analysis, male Slitrk4 KO mice exhibited an enhanced fear memory acquisition in a cued test for classical fear conditioning, and social behavior deficits in reciprocal social interaction tests. In an electrophysiological analysis using amygdala slices, Slitrk4 KO mice showed enhanced long-term potentiation in the thalamo-amygdala afferents and reduced feedback inhibition. In the molecular marker analysis of Slitrk4 KO brains, the number of calretinin (CR)-positive interneurons was decreased in the anterior part of the lateral amygdala nuclei at the adult stage. In

Indexed as

amygdalacell type specificationfear memorygene targetinginhibitory neuronneural plasticityposttraumatic stress disorderSlitrk4

Identifiers

PMID38736483
PMCPMC11082273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.